Gene · 10155
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer. | Cell Rep | 2023 | 37865915 | PubTator, text mining | PubMed |
| E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells. | J Exp Clin Cancer Res | 2023 | 37865804 | PubTator, text mining | PubMed |
| Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review. | Autoimmun Rev | 2023 | 37863375 | PubTator, text mining | PubMed |
| Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma. | Transl Cancer Res | 2023 | 37859737 | PubTator, text mining | PubMed |
| CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model. | Aging (Albany NY) | 2023 | 37857018 | PubTator, text mining | PubMed |
| ATM, KAP1 and the Epstein-Barr virus polymerase processivity factor direct traffic at the intersection of transcription and replication. | Nucleic Acids Res | 2023 | 37852757 | PubTator, text mining | PubMed |
| Structural Evolution of Gene Promoters Driven by Primate-Specific KRAB Zinc Finger Proteins. | Genome Biol Evol | 2023 | 37847041 | PubTator, text mining | PubMed |
| Expanding PROTACtable genome universe of E3 ligases. | Nat Commun | 2023 | 37845222 | PubTator, text mining | PubMed |
| Hypoxia-induced transcriptional stress is mediated by ROS-induced R-loops. | Nucleic Acids Res | 2023 | 37843099 | PubTator, text mining | PubMed |
| Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer. | Cancers (Basel) | 2023 | 37835536 | PubTator, text mining | PubMed |
| Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions. | Int J Mol Sci | 2023 | 37834078 | PubTator, text mining | PubMed |
| ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance. | Nucleic Acids Res | 2023 | 37823600 | Swiss-Prot, curated | PubMed |
| Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment. | Front Immunol | 2023 | 37822925 | PubTator, text mining | PubMed |
| Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk. | J Transl Med | 2023 | 37814317 | PubTator, text mining | PubMed |
| The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia. | EMBO Mol Med | 2023 | 37807875 | PubTator, text mining | PubMed |
| URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. | Nat Commun | 2023 | 37805657 | PubTator, text mining | PubMed |
| CoCl2 -triggered pseudohypoxic stress induces proteasomal degradation of SIRT4 via polyubiquitination of lysines K78 and K299. | FEBS Open Bio | 2023 | 37803520 | PubTator, text mining | PubMed |
| The N-terminus of Stag1 is required to repress the 2C program by maintaining rRNA expression and nucleolar integrity. | Stem Cell Reports | 2023 | 37802073 | PubTator, text mining | PubMed |
| Post-translational modifications and their implications in cancer. | Front Oncol | 2023 | 37795435 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens and their applications in infectious disease. | Front Genome Ed | 2023 | 37794981 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10155/papers?page=20